Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor

Artificial Tears Companies

ID: MRFR/HC/10538-CR
128 Pages
Rahul Gotadki
Last Updated: February 16, 2025
Artificial tears are eye drops or ointments designed to lubricate the eyes and provide relief from dryness and discomfort. These products are commonly used to treat conditions such as dry eye syndrome, which can result from factors like aging, environmental conditions, prolonged screen time, or certain medical conditions.
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Artificial Tears Market

Market Size

Forecast Period2025 - 2035
CAGR (2025 - 2035)6.48%
2024 Market Size$ 3.5 Billion
2025 Market Size$ 3.73 Billion
2035 Market Size$ 6.99 Billion

Key Players

Allergan
Santen
Bausch Health
Novartis
Johnson & Johnson
Alcon
Opportunities
  • Growth in Contact Lens Usage
  • Increase in Aging Population
  • Rising Awareness of Eye Health

Top Industry Leaders in the Artificial Tears Market

Artificial Tears Key Companies
ย 
Latestย Artificial Tearsย Companies Update:

Recall Updates In February 2023, the FDA issued a recall for EzriCare Artificial Tears and Delsam Pharma's Artificial Eye Ointment due to potential bacterial contamination. This incident highlighted the importance of manufacturing quality and safety in the artificial tears market.

Allergan (US) Launched Refreshยฎ Bio, a new line of preservative-free and biocompatible artificial tears in July 2023, catering to users with sensitive eyes or preservative allergies.

Bausch + Lomb (US) Announced plans to expand its line of Systaneยฎ Complete artificial tears with new formulations addressing specific dry eye symptoms, offering targeted relief options for patients.

Johnson & Johnson (US) Received FDA approval for its Acuvueยฎ Oasys with TearRelief Technology contact lenses in September 2023, which integrate a moisturizing agent within the lens for enhanced comfort and dryness relief.

Thea Laboratories (France) Collaborated with AI startup TearLab Corp. (US) to develop AI-powered diagnostic tools for personalized dry eye management, aiming to tailor treatment plans based on individual tear film analysis.

List ofย Artificial Tearsย Key companies in the market
  • Johnson and Johnson Vision Care (US)
  • Allergan plc (Ireland)
  • Alcon Plc (Switzerland)
  • Bausch & Lomb Incorporated (Canada)
  • Santen, Inc (Japan)
  • URSAPHARM Arzneimittel GmbH (Germany)
  • ROHTO Pharmaceutical CO., LTD (Japan)
  • Similasan Corporation (US)
  • Ocusoft (US)
  • Nicox (France)